Cel AI PLC (CLAI.L) Research

Operating with its subsidiaries, Cel AI PLC produces and distributes consumer items infused with biosynthetic cannabinoids across the United Kingdom. Their product range includes cannabinoid-based solutions designed for both topical skincare and ingestible applications. These goods reach consumers through various channels: traditional retailers, direct online sales via the company's website, and other digital platforms. The organization, which began trading in 2018, was formerly named Cellular Goods PLC before officially adopting the Cel AI PLC moniker in February 2024. Its operational base is located in London, United Kingdom.

Market snapshot

Symbol
CLAI.L
Price
$0.13
Day change
-1.96%
Market cap
$815.1K
P/E ratio
-0.41x
52-week range
0.03-0.94
Sector
Consumer Defensive
Industry
Household & Personal Products

Peer companies

  • Agriterra Limited (AGTA.L)
  • Byotrol plc (BYOT.L)
  • East Imperial PLC (EISB.L)
  • Ocean Harvest Technology Group plc (OHT.L)
  • Real Good Food plc (RGD.L)

Open Cel AI PLC (CLAI.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.